Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction

NCT06703840 is registered in ClinicalTrials.gov with Dicot AB as lead sponsor.

NCT NCT06703840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction
Lead sponsor
Dicot AB
Phase
Phase 2
Overall status
Completed
Start date
November 8, 2024
Completion date
August 19, 2025
Enrollment
156 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction